Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma Front Oncol
Protein features instruct the secretion dynamics from metal-supported synthetic amyloids Int J Biol Macromol
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors Front Immunol
Impact of Prolonged Ischemia on the Immunohistochemical Expression of Programmed Death Ligand 1 (PD-L1) APPL IMMUNOHISTO M M
Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia Transl Pediatr
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature LEUKEMIA LYMPHOMA
High-precision targeting and destruction of cancer-associated PDGFR-β(+) stromal fibroblasts through self-assembling, protein-only nanoparticles Acta Biomater
Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations J Clin Med